D-0232-2015 Class II Terminated
FDA drug recall D-0232-2015 was initiated by Actavis Inc on Aug 25, 2014 and is designated Class II. Reason for recall: Subpotent Drug The recall status is terminated (terminated Mar 21, 2018). Affected quantity: 26,663 cartons.
Recall details
- Product Type
- Drugs
- Report Date
- Nov 5, 2014
- Initiation Date
- Aug 25, 2014
- Termination Date
- Mar 21, 2018
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 26,663 cartons
Product description
Vancomycin Hydrochloride Capsule, USP, 125 mg, 20 count blister pack, Rx Only, Mfd. for: Watson Pharma. Inc. Parsippany, NJ 07054 USA, Mfd. by: Patheon Pharmaceuticals Inc. Cincinnati, OH 45237 USA ---- NDC 0591-3560-15 UPC Code 3-0591356015-4
Reason for recall
Subpotent Drug
Distribution pattern
Nationwide
Code information
3103681, exp Aug 2014, 3104886, exp Oct 2014, 3105836, exp Dec 2014, and 3106650, exp Dec 2014
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0232-2015
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026